R 142086

Known as: R-142086, R142086 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Use of an intravenous microdose of 14C-labeled drug and accelerator mass spectrometry to measure absolute oral bioavailability in dogs; cross-comparison of assay methods by accelerator mass…
A technique utilizing simultaneous intravenous microdosing of (14)C-labeled drug with oral dosing of non-labeled drug for… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2009
2009
Discovery of R-142086 as a factor Xa (FXa) inhibitor: syntheses and structure-activity relationships of cinnamyl derivatives.
To develop a novel and effective anticoagulant with potent and selective factor Xa (FXa) inhibitory activity, a new series of… (More)
  • table 1
  • table 3
  • table 2
  • table 4
  • table 5
Is this relevant?
2009
2009
Discovery of R-142086 as a Factor Xa (FXa) Inhibitor: Syntheses and Structure—Activity Relationships of Cinnamyl Derivatives.
 
Is this relevant?